Kenneth H. Davis

1.0k total citations
21 papers, 732 citations indexed

About

Kenneth H. Davis is a scholar working on Pharmacology, Molecular Biology and Toxicology. According to data from OpenAlex, Kenneth H. Davis has authored 21 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Toxicology. Recurrent topics in Kenneth H. Davis's work include Cannabis and Cannabinoid Research (10 papers), Forensic Toxicology and Drug Analysis (4 papers) and Natural product bioactivities and synthesis (3 papers). Kenneth H. Davis is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Forensic Toxicology and Drug Analysis (4 papers) and Natural product bioactivities and synthesis (3 papers). Kenneth H. Davis collaborates with scholars based in United States. Kenneth H. Davis's co-authors include Mario Perez‐Reyes, M. Chrystie Timmons, Monroe E. Wall, Morris A. Lipton, C. E. Cook, Dolores R. Brine, David Rosenthal, H. Dix Christensen, Harold L. Taylor and C. H. Hanson and has published in prestigious journals such as Science, JAMA and The Journal of Organic Chemistry.

In The Last Decade

Kenneth H. Davis

20 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth H. Davis United States	13	525	225	215	104	74	21	732
A. Wahlén Sweden	9	537 1.0×	241 1.1×	192 0.9×	99 1.0×	62 0.8×	12	745
Dolores R. Brine United States	16	634 1.2×	295 1.3×	306 1.4×	158 1.5×	127 1.7×	27	1.1k
Magnus M. Halldin Sweden	18	713 1.4×	264 1.2×	289 1.3×	208 2.0×	111 1.5×	50	1.3k
Howard Rowe United States	16	458 0.9×	250 1.1×	103 0.5×	61 0.6×	89 1.2×	29	852
Ross H. Lowe United States	13	404 0.8×	145 0.6×	332 1.5×	135 1.3×	87 1.2×	16	709
Andreas M. Stadelmann Germany	10	418 0.8×	234 1.0×	89 0.4×	65 0.6×	68 0.9×	14	668
E. J. Cone United States	12	335 0.6×	144 0.6×	371 1.7×	90 0.9×	75 1.0×	14	697
R.B. Forney United States	15	303 0.6×	203 0.9×	92 0.4×	43 0.4×	102 1.4×	60	654
J.‐E. Lindgren Sweden	15	937 1.8×	387 1.7×	291 1.4×	141 1.4×	126 1.7×	27	1.3k
Agneta Ohlsson Sweden	7	359 0.7×	134 0.6×	116 0.5×	64 0.6×	24 0.3×	8	434

Countries citing papers authored by Kenneth H. Davis

Since Specialization

Citations

This map shows the geographic impact of Kenneth H. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth H. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth H. Davis more than expected).

Fields of papers citing papers by Kenneth H. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth H. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth H. Davis. The network helps show where Kenneth H. Davis may publish in the future.

Co-authorship network of co-authors of Kenneth H. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth H. Davis. A scholar is included among the top collaborators of Kenneth H. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth H. Davis. Kenneth H. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, Kenneth H., et al.. (2023). A novel adaptation of spatial interpolation methods to map health attitudes related to COVID-19. BMC Proceedings. 17(S7). 17–17.

Grabenauer, Megan, Anderson O. Cox, Kenneth H. Davis, et al.. (2014). Pyrolysis studies of synthetic cannabinoids in herbal products. Drug and Alcohol Dependence. 140. e44–e44. 6 indexed citations

Cox, Anderson O., Malcolm D. Mason, Megan Grabenauer, et al.. (2012). Use of SPME-HS-GC-MS for the Analysis of Herbal Products Containing Synthetic Cannabinoids. Journal of Analytical Toxicology. 36(5). 293–302. 29 indexed citations

Biles, William E., et al.. (1995). Computer-aided design and rapid tool development in injection molding processes. Computers & Industrial Engineering. 29(1-4). 659–662. 5 indexed citations

Flora, Karl P., et al.. (1990). Stability of morphine sulfate in infusion devices and containers for intravenous administration. American Journal of Health-System Pharmacy. 47(1). 143–146. 12 indexed citations

Flora, Karl P., et al.. (1990). Stability of Heroin Hydrochloride in Infusion Devices and Containers for Intravenous Administration. American Journal of Health-System Pharmacy. 47(2). 377–381. 12 indexed citations

Cook, C. E., et al.. (1986). Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette.. PubMed. 6(5). 361–9. 21 indexed citations

Perez‐Reyes, Mario, et al.. (1983). Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clinical Pharmacology & Therapeutics. 34(1). 36–41. 55 indexed citations

Perez‐Reyes, Mario, et al.. (1982). Comparison of effects of marihuana cigarettes of three different potencies. Clinical Pharmacology & Therapeutics. 31(5). 617–624. 103 indexed citations

10.

Davis, Kenneth H., et al.. (1974). Saponins of two alfalfa cultivars. Phytochemistry. 13(10). 2253–2260. 12 indexed citations

11.

Pedersen, M. W., et al.. (1973). Modification of Saponin Characteristics of Alfalfa by Selection¹. Crop Science. 13(6). 731–735. 16 indexed citations

12.

Timmons, M. Chrystie, et al.. (1973). A comparison of the pharmacological activity ofgD 9-Tetrahydrocannabinol and its monohydroxylated metabolites in man. Cellular and Molecular Life Sciences. 29(8). 1009–1010. 33 indexed citations

13.

Lipton, Morris A., et al.. (1973). Pharmacology of orally administered Δ⁹‐tetrahydrocannabinol. Clinical Pharmacology & Therapeutics. 14(1). 48–55. 80 indexed citations

14.

Perez‐Reyes, Mario, et al.. (1973). A comparison of the pharmacological activity in man of intravenously administered 1368-11368-11368-1, cannabinol, and cannabidiol. Cellular and Molecular Life Sciences. 29(11). 1368–1369. 135 indexed citations

15.

Davis, Kenneth H., et al.. (1973). Preparation of Δ9-tetrahydrocannabinol for intravenous injection. Journal of Pharmacy and Pharmacology. 25(4). 344–344. 23 indexed citations

16.

Leath, K. T., Kenneth H. Davis, Monroe E. Wall, & C. H. Hanson. (1972). Vegetative Growth Responses of Alfalfa Pathogens to Saponin and Other Extracts from Alfalfa (Medicago sativa L.)¹. Crop Science. 12(6). 851–856. 11 indexed citations

17.

Perez‐Reyes, Mario, M. Chrystie Timmons, Morris A. Lipton, Kenneth H. Davis, & Monroe E. Wall. (1972). Intravenous Injection in Man of Δ ⁹ -Tetrahydrocannabinol and 11-OH-Δ ⁹ -Tetrahydrocannabinol. Science. 177(4049). 633–635. 105 indexed citations

18.

Wall, Monroe E., Harold L. Taylor, Linda Ambrosio, & Kenneth H. Davis. (1969). Plant Antitumor Agents III: A Convenient Separation of Tannins from Other Plant Constituents. Journal of Pharmaceutical Sciences. 58(7). 839–841. 21 indexed citations

19.

Rosenthal, David & Kenneth H. Davis. (1966). Some alkylations of 2-methylcyclopentane-1,3-dione. Journal of the Chemical Society C Organic. 1973–1973. 1 indexed citations

20.

Rosenthal, David, et al.. (1965). The Synthesis of β-Amino Mercaptans and β-Amino Thiosulfates via Ethylenimine Intermediates¹. The Journal of Organic Chemistry. 30(11). 3689–3696. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact